Polybiotin compounds for magnetic resonance imagining and drug delivery

Details for Australian Patent Application No. 2004277403 (hide)

Owner The General Hospital Corporation

Inventors Shoup, Timothy M.; Elmaleh, David R.; Fischman, Alan J.

Agent Shelston IP

Pub. Number AU-A-2004277403

PCT Pub. Number WO2005/032598

Priority 60/508,152 02.10.03 US

Filing date 1 October 2004

Wipo publication date 14 April 2005

International Classifications

A61B 5/00 (2006.01) Measuring for diagnostic purposes

A61B 5/055 (2006.01) Measuring for diagnostic purposes - involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging

A61K 49/08 (2006.01) Preparations for testing

A61K 51/04 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

G01R 33/28 (2006.01) Arrangements or instruments for measuring magnetic variables - Details of apparatus provided for in groups

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/032598 Priority application(s): WO2005/032598

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004277405-Substituted benzazoles and use thereof as inhibitors of Raf kinase

2004277402-In vivo efficacy of NY-ESO-1 plus adjuvant